ReviewCancers2022

Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies.

Mila S Griffioen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.